Unpacking the 2026 Dyslipidemia Guideline
Webinar Overview
Join us for a deep dive into the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia as it relates to your clinical practice.
The newly released 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia includes a tremendous amount of valuable information on key areas of managing dyslipidemia including lipid goals, imaging, biomarkers, risk algorithms, lifestyle therapies and advanced therapeutics. This webinar, hosted by ACC's Prevention of Cardiovascular Disease Member Section, will review the Guideline's key highlights and include an extensive discussion about its impact on clinical care. Guideline authors and international experts will lead a short summary presentation and an engaging discussion, followed by a Q&A.
Key Objectives/Learning Outcomes:
- Appreciate the key differences from the prior dyslipidemia guideline.
- Understand the updated goals for lipid levels.
- Be familiar with risk algorithms and treatment approaches.
Webinar Participants
Eugenia Gianos, MD, FACC
Roger Blumenthal, MD, FACC
Konstantinos Koskinas, MD
Joseph Saseen, PharmD, FACC
John Wilkins, MD
Heather Johnson, MD, MS, FACC
Ann Marie Navar, MD, FACC
Credit Information
No credit is being offered for this webinar.
Clinical Topics: Dyslipidemia, Prevention
Keywords: